- Home
- CNMD vs PEB Comparison
CNMD vs PEB Comparison
Compare CNMD & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNMD | PEB |
|---|---|---|
| Founded | 1970 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1987 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CNMD | PEB |
|---|---|---|
| Price | $41.65 | $12.73 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $51.20 | $12.35 |
| AVG Volume (30 Days) | 627.5K | ★ 2.1M |
| Earning Date | 01-28-2026 | 02-25-2026 |
| Dividend Yield | ★ 1.44% | 0.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | $1,374,724,000.00 | ★ $1,464,126,000.00 |
| Revenue This Year | $1.84 | $2.04 |
| Revenue Next Year | $5.21 | N/A |
| P/E Ratio | $27.68 | ★ N/A |
| Revenue Growth | ★ 5.18 | 0.99 |
| 52 Week Low | $35.37 | $7.42 |
| 52 Week High | $65.50 | $13.11 |
Technical Indicators
Market Signals| Indicator | CNMD | PEB |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 55.42 |
| Support Level | $41.06 | $12.22 |
| Resistance Level | $43.84 | $13.11 |
| Average True Range (ATR) | 1.86 | 0.45 |
| MACD | 0.34 | 0.07 |
| Stochastic Oscillator | 83.71 | 57.30 |
Price Performance
Historical ComparisonAbout CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.